Latest News & Features
Americas
Big pharma subsidiary and Japanese collaborator allege infringement of blockbuster drug product | $1.2 billion treatment developed by University of California. 6 August 2024
Americas
Pharma company argues that affirming lower court’s decision would shrink Orange Book “dramatically” | District court found Teva’s patents do not claim the drug product for which they are listed. 1 August 2024
Americas
Being a lawyer with ADHD is far from easy due to widespread misconceptions about the condition but there are ways to offer support, says Lisa Mueller of Casimir Jones. 1 August 2024
Americas
Senior partner in IP department will become co-managing partner | Foley Hoag elected three other members of five-strong executive committee this year 1 August 2024
Americas
Biopharmaceutical company insisted its cancer treatment should be considered a biologic | Panel finds “unfairly reductive” arguments “just don’t work” | FDA correct to reject Ipsen based on faulty scientific expertise. 30 July 2024
Americas
Massachusetts biotech giants clash as Genzyme alleges Sarepta's Elevidys infringes on key gene therapy patents | Despite the dispute, Elevidys $200M in sales and recent FDA approvals show success. 30 July 2024
Americas
Hongene Biotech challenged ChemGenes’ patent after litigation withdrawn | Judges said all challenged claims were unpatentable. 25 July 2024
Biotechnology
AI has the potential to revolutionise patent examination but uneven adoption of the technology could undermine fairness in the system, says Matthew Veale of Patsnap. 25 July 2024
Americas
The appointee represents a diverse range of tech clients, including in medtech and life sciences and will now lead the firm’s California offices. 25 July 2024
Americas
Scientist and patent attorney joins boutique IP firm in Philadelphia | Former in-house counsel brings expertise representing variety of life sciences clients. 25 July 2024